Last reviewed · How we verify
NCT01615900: TELEGRAFT
Randomized Open Label Study Evaluating the Coverage by Teleconsultation Versus Standard Follow-up of Renal Transplant Patients According to a Risk Score of Early Graft Failure (KTFS)
NA trial testing Teleconsultation / Standard consultation in Renal Transplant Patient in 155 participants. Completed in 7 January 2020.
7 January 2020
Quick facts
| Lead sponsor | Nantes University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 155 |
| Start date | 7 February 2012 |
| Primary completion | 7 January 2020 |
| Estimated completion | 7 January 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- Teleconsultation / Standard consultation
Conditions studied
- Renal Transplant Patient — all drugs for Renal Transplant Patient →
Sponsor
Nantes University Hospital
Who can join
18 and older, any sex, with Renal Transplant Patient. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of this study is to optimize the coverage of renal transplant patients thanks to a personalized follow-up based on a risk score of early graft failure (KTFS, Kidney Transplant Failure Score), associated with teleconsultations.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A personalized follow-up of kidney transplant recipients using video conferencing based on a 1-year scoring system predictive of long term graft failure (TELEGRAFT study): protocol for a randomized controlled trial.
Foucher Y, Meurette A, Daguin P, Bonnaud-Antignac A, et al · · 2015 · cited 17× · PMID 25631635 · DOI 10.1186/1471-2369-16-6 -
The EKiTE network (epidemiology in kidney transplantation - a European validated database): an initiative epidemiological and translational European collaborative research.
Lorent M, Foucher Y, Kerleau K, Brouard S, et al · · 2019 · cited 13× · PMID 31601177 · DOI 10.1186/s12882-019-1522-8
Verify or expand the search:
- PubMed search for NCT01615900
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Nantes University Hospital trials
Trials by the same sponsor.
- NCT07278661 — Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. · Phase 2 · recruiting
- NCT06681363 — Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelod · not yet recruiting
- NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
- NCT07490379 — Comparison of the Efficacy of Transcranial Direct Current Stimulation at Home Versus in Hospital Settings in Patients Wi · NA · not yet recruiting
- NCT07423481 — Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01615900 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nantes University Hospital
- Last refreshed: 13 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01615900.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing